J Cosmet Med 2021; 5(2): 94-98
Published online December 31, 2021
Ibrahim AlQuniabut, MD1 , Hye Jeen Kim, MD2
, Seong Yong Moon, MD, PhD3
, Ji Yun Choi, MD, PhD2
1Department of Surgery, Unaizah College of Medicine and Medical Sciences, Qassim University, Buraydah, Kingdom of Saudi Arabia
2Department of Otolaryngology-Head and Neck Surgery, Chosun University College of Medicine, Gwangju, Rep. of Korea
3Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University, Gwangju, Rep. of Korea
Correspondence to :
Ji Yun Choi
E-mail: happyent@naver.com
© Korean Society of Korean Cosmetic Surgery and Medicine (KSKCS & KCCS)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
A 77-year-old male presented to our clinic with right cheek swelling, pain, and discharge for 1 month. Oral cavity examination revealed a draining fistula in the hard palate and a tender mass over the right cheek. An enhanced computed tomography scan of the paranasal sinuses showed an enhancing mass with maxillary bone destruction. Fine needle aspiration revealed the presence of pus cells and mucoid material with negative malignant cells. Debridement of loose necrotic tissue resulted in bone necrosis. Therefore, we diagnosed the patient with osteomyelitis induced by antiresorptive medications. A multicourse antibiotic regimen based on culture and sensitivity was initiated, and the patient showed a clinical and radiological response to healing. The patient later developed facial disfiguration due to soft tissue and bone defects with dysfunction of oral competence.
Keywords: bisphosphonate, denosumab, facial deformity, maxilla, osteonecrosis
J Cosmet Med 2021; 5(2): 94-98
Published online December 31, 2021 https://doi.org/10.25056/JCM.2021.5.2.94
Copyright © Korean Society of Korean Cosmetic Surgery and Medicine (KSKCS & KCCS).
Ibrahim AlQuniabut, MD1 , Hye Jeen Kim, MD2
, Seong Yong Moon, MD, PhD3
, Ji Yun Choi, MD, PhD2
1Department of Surgery, Unaizah College of Medicine and Medical Sciences, Qassim University, Buraydah, Kingdom of Saudi Arabia
2Department of Otolaryngology-Head and Neck Surgery, Chosun University College of Medicine, Gwangju, Rep. of Korea
3Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University, Gwangju, Rep. of Korea
Correspondence to:Ji Yun Choi
E-mail: happyent@naver.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
A 77-year-old male presented to our clinic with right cheek swelling, pain, and discharge for 1 month. Oral cavity examination revealed a draining fistula in the hard palate and a tender mass over the right cheek. An enhanced computed tomography scan of the paranasal sinuses showed an enhancing mass with maxillary bone destruction. Fine needle aspiration revealed the presence of pus cells and mucoid material with negative malignant cells. Debridement of loose necrotic tissue resulted in bone necrosis. Therefore, we diagnosed the patient with osteomyelitis induced by antiresorptive medications. A multicourse antibiotic regimen based on culture and sensitivity was initiated, and the patient showed a clinical and radiological response to healing. The patient later developed facial disfiguration due to soft tissue and bone defects with dysfunction of oral competence.
Keywords: bisphosphonate, denosumab, facial deformity, maxilla, osteonecrosis